MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from common
stock and pre-funded...
$12,102K
Proceeds from exercise of
common stock warrants
$25K
Proceeds from exercise of
stock options
$17K
Net cash provided by
financing activities
$10,845K
Canceled cashflow
$1,299K
Change in cash and cash
equivalents
-$130K
Canceled cashflow
$10,845K
Stock-based compensation
expense
$1,267K
Accounts payable
$213K
Prepaid expenses
-$90K
Non-cash lease expense
$88K
Depreciation
$2K
Costs of issuance of
common stock upon...
$1,299K
Net cash used in
operating activities
-$10,973K
Canceled cashflow
$1,660K
Net cash used in
investing activities
-$2K
Net income (loss)
-$11,168K
Fair value
adjustment on common...
-$915K
Accrued expenses
-$265K
Inventory
$189K
Accounts receivable
$96K
Purchase of property and
equipment
$2K
Back
Back
Cash Flow
source: myfinsight.com
RenovoRx, Inc. (RNXT)
RenovoRx, Inc. (RNXT)